Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

Similar articles for PubMed (Select 15064745)

1.

Deregulated expression of LRBA facilitates cancer cell growth.

Wang JW, Gamsby JJ, Highfill SL, Mora LB, Bloom GC, Yeatman TJ, Pan TC, Ramne AL, Chodosh LA, Cress WD, Chen J, Kerr WG.

Oncogene. 2004 May 20;23(23):4089-97.

PMID:
15064745
2.

p53-dependent down-regulation of telomerase is mediated by p21waf1.

Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, Kogan I, Braunstein I, Tzukerman M, Ginsberg D, Rotter V.

J Biol Chem. 2004 Dec 3;279(49):50976-85. Epub 2004 Sep 15.

3.

EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.

Novy M, Pohn R, Andorfer P, Novy-Weiland T, Galos B, Schwarzmayr L, Rotheneder H.

Mol Biol Cell. 2005 May;16(5):2181-90. Epub 2005 Feb 16.

4.

Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.

Chen D, Padiernos E, Ding F, Lossos IS, Lopez CD.

Cell Death Differ. 2005 Apr;12(4):358-68.

5.
6.

ASPP1 and ASPP2 are new transcriptional targets of E2F.

Fogal V, Kartasheva NN, Trigiante G, Llanos S, Yap D, Vousden KH, Lu X.

Cell Death Differ. 2005 Apr;12(4):369-76.

7.

Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.

Davis JN, McCabe MT, Hayward SW, Park JM, Day ML.

Cancer Res. 2005 May 1;65(9):3633-42.

8.

Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.

Hershko T, Chaussepied M, Oren M, Ginsberg D.

Cell Death Differ. 2005 Apr;12(4):377-83.

9.
10.

Aberrant regulation of survivin by the RB/E2F family of proteins.

Jiang Y, Saavedra HI, Holloway MP, Leone G, Altura RA.

J Biol Chem. 2004 Sep 24;279(39):40511-20. Epub 2004 Jul 22.

11.

AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.

Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.

Oncogene. 2004 Oct 28;23(50):8238-46.

PMID:
15378019
12.

Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.

Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, Rezaei N, Kyroudi A, Kittas C, Patsouris E, Papavassiliou AG, Gorgoulis VG.

J Pathol. 2004 Jul;203(3):744-53.

PMID:
15221933
13.

The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.

Jeong Seo E, Jung Kim H, Jae Lee C, Tae Kang H, Seong Hwang E.

Gynecol Oncol. 2004 Jul;94(1):40-7.

PMID:
15262117
14.

Co-regulation of B-Myb expression by E2F1 and EGF receptor.

Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC.

Mol Carcinog. 2006 Jan;45(1):10-7.

PMID:
16299810
15.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
16.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
17.

17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways.

Ru Lee W, Chen CC, Liu S, Safe S.

J Cell Biochem. 2006 Sep 1;99(1):209-20.

PMID:
16598773
18.

E1A activates transcription of p73 and Noxa to induce apoptosis.

Flinterman M, Guelen L, Ezzati-Nik S, Killick R, Melino G, Tominaga K, Mymryk JS, Gäken J, Tavassoli M.

J Biol Chem. 2005 Feb 18;280(7):5945-59. Epub 2004 Nov 29.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk